Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Warfarin treatment after bioprosthetic aortic valve replacement.

Toeg HD, Bjerre LM, Ruel M.

JAMA. 2013 Mar 27;309(12):1225. doi: 10.1001/jama.2013.1972. No abstract available.

PMID:
23532228
2.

Warfarin treatment after bioprosthetic aortic valve replacement--reply.

Mérie C, Køber L, Torp-Pedersen C.

JAMA. 2013 Mar 27;309(12):1225-6. doi: 10.1001/jama.2013.1978. No abstract available.

PMID:
23532229
3.

Warfarin after bioprosthetic aortic valve implantation.

Mehta SR, Weitz JI.

JAMA. 2012 Nov 28;308(20):2147-8. doi: 10.1001/jama.2012.91476. No abstract available. Erratum in: JAMA. 2013 Mar 27;309(12):1229.

PMID:
23188033
4.

Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding.

Mérie C, Køber L, Skov Olsen P, Andersson C, Gislason G, Skov Jensen J, Torp-Pedersen C.

JAMA. 2012 Nov 28;308(20):2118-25. doi: 10.1001/jama.2012.54506.

PMID:
23188028
5.

Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?

ElBardissi AW, DiBardino DJ, Chen FY, Yamashita MH, Cohn LH.

J Thorac Cardiovasc Surg. 2010 May;139(5):1137-45. doi: 10.1016/j.jtcvs.2009.10.064. Epub 2010 Mar 19.

6.

Use of artificial neural network to predict warfarin individualized dosage regime in Chinese patients receiving low-intensity anticoagulation after heart valve replacement.

Zhou Q, Kwong J, Chen J, Qin W, Chen J, Dong L; CLIATHVR multicenter clinical study team.

Int J Cardiol. 2014 Oct 20;176(3):1462-4. doi: 10.1016/j.ijcard.2014.08.062. Epub 2014 Aug 17. No abstract available.

PMID:
25164187
7.

Low-intensity international normalized ratio (INR) oral anticoagulant therapy in Chinese patients with mechanical heart valve prostheses.

Haibo Z, Jinzhong L, Yan L, Xu M.

Cell Biochem Biophys. 2012 Jan;62(1):147-51. doi: 10.1007/s12013-011-9275-4.

PMID:
21892782
8.

Importance of long-term anticoagulation in both prosthetic and biological tricuspid valve replacements.

Rafiq I, Freeman LJ, Wood S.

Ann Thorac Surg. 2007 Oct;84(4):1424; author reply 1425. No abstract available.

PMID:
17889027
9.

Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement?

Sundt TM, Zehr KJ, Dearani JA, Daly RC, Mullany CJ, McGregor CG, Puga FJ, Orszulak TA, Schaff HV.

J Thorac Cardiovasc Surg. 2005 May;129(5):1024-31.

10.

Long-term performance of the St. Jude Medical valve: low incidence of thromboembolism and hemorrhagic complications with modest doses of warfarin.

Kopf GS, Hammond GL, Geha AS, Elefteriades J, Hashim SW.

Circulation. 1987 Sep;76(3 Pt 2):III132-6.

PMID:
3621536
11.

Evaluation of anticoagulant therapy in cloth-covered prosthetic valves.

Isom OW, Williams CD, Falk EA, Spencer FC, Glassman E.

Circulation. 1973 Jul;48(1 Suppl):III48-50. No abstract available.

PMID:
4721281
12.

Routine aortic valve replacement for mild stenosis is not necessary during rheumatic mitral surgery.

Hwang HY, Ahn H.

J Thorac Cardiovasc Surg. 2014 Dec;148(6):3255. doi: 10.1016/j.jtcvs.2014.09.125. No abstract available.

13.

Anticoagulation after bioprosthetic aortic valve replacement.

Nowell J, Jahangiri M.

J Thorac Cardiovasc Surg. 2010 Nov;140(5):1201-2; author reply 1202. doi: 10.1016/j.jtcvs.2010.06.058. No abstract available.

14.

[Haemorrhagic and thrombo-embolic complications in patients with prosthetic valves--the under-appreciated problem with no safe solutions].

Trzeciak P, Poloński L, Zembala M.

Kardiol Pol. 2006 Sep;64(9):1038-42. Review. Polish. No abstract available.

15.

[Anticoagulation in chinese patients with carbomedics mechanical prosthetic heart valves].

Zhuang W, Zhou XM, Hu JG, Li JM, Yu JF, Jiang L, Hu DX.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2004 Aug;29(4):460-2. Chinese.

16.

Comparison of anticoagulation regimens after Carpentier-Edwards aortic or mitral valve replacement.

Blair KL, Hatton AC, White WD, Smith LR, Lowe JE, Wolfe WG, Young WG, Oldham HN, Douglas JM Jr, Glower DD.

Circulation. 1994 Nov;90(5 Pt 2):II214-9.

PMID:
7955256
17.

Early postoperative thrombosis of an aortic bioprosthetic valve: should anticoagulation be patient specific?

Efthymiou CA, Mills RJ, O'Regan DJ.

J Card Surg. 2013 Nov;28(6):723-9. doi: 10.1111/jocs.12181. Epub 2013 Sep 2. Review.

PMID:
23992398
18.

Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-X valve anticoagulation clinical trial randomized Food and Drug Administration investigational device exemption trial.

Puskas J, Gerdisch M, Nichols D, Quinn R, Anderson C, Rhenman B, Fermin L, McGrath M, Kong B, Hughes C, Sethi G, Wait M, Martin T, Graeve A; PROACT Investigators.

J Thorac Cardiovasc Surg. 2014 Apr;147(4):1202-1210; discussion 1210-1. doi: 10.1016/j.jtcvs.2014.01.004. Epub 2014 Jan 12.

19.

Influence of the On-X mechanical prosthesis on intermediate-term major thromboembolism and hemorrhage: a prospective multicenter study.

Chan V, Jamieson WR, Lam BK, Ruel M, Ling H, Fradet G, Mesana TG.

J Thorac Cardiovasc Surg. 2010 Nov;140(5):1053-8.e2. doi: 10.1016/j.jtcvs.2009.10.068. Epub 2010 May 23.

20.

Mechanical aortic valve replacement in young women planning on pregnancy: maternal and fetal outcomes under low oral anticoagulation, a pilot observational study on a comprehensive pre-operative counseling protocol.

De Santo LS, Romano G, Della Corte A, D'Oria V, Nappi G, Giordano S, Cotrufo M, De Feo M.

J Am Coll Cardiol. 2012 Mar 20;59(12):1110-5. doi: 10.1016/j.jacc.2011.10.899.

Supplemental Content

Support Center